Ran Xu

6PUBLICATIONS
59CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.

Ran Xu, Gongwei Wu, Siobhan Rice

|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|Jun 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|May 08, 2024
Targetable leukaemia dependency on noncanonical PI3Kγ signalling.

Qingyu Luo, Evangeline G Raulston, Miguel A Prado

|Sep 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.

Gongwei Wu, Noriaki Yoshida, Jihe Liu

|Dec 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.

Wenchao Wu, Geoffrey M Nelson, Raphael Koch

Pageof 1

Frequent Collaborators

4 joint publications

Ajit J Nirmal

4 joint publications

David M Weinstock

3 joint publications

Gongwei Wu

3 joint publications

Steven M Horwitz